Loading…
CIK 0001274403 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("arch-venture-management-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 10X GENOMICS INC. | CL A COM | $12.0M | 1.8% | 737,539 SH | New |
| BEAM THERAPEUTICS INC. | COM | $125.9M | 19.3%Prev: 22.4% | 4,540,132 SH | Increased |
| ERASCA INC. | COM | $41.1M | 6.3%Prev: 4.9% | 11,055,554 SH | Increased |
| GOSSAMER BIO INC. | COM | $25.0M | 3.8%Prev: 4.3% | 8,055,916 SH | Increased |
| LYELL IMMUNOPHARMA INC. | COM NEW | $84.9M | 13.0%Prev: 9.1% | 2,759,072 SH | Increased |
| MAZE THERAPEUTICS INC. | COM | $170.7M | 26.2%Prev: 21.7% | 4,120,053 SH | Increased |
| Q32 BIO INC. | COM | $1.1M | 0.2%Prev: 0.1% | 320,482 SH | Increased |
| RAPPORT THERAPEUTICS INC. | COM | $113.1M | 17.4%Prev: 22.5% | 3,728,738 SH | Increased |
| VIR BIOTECHNOLOGY INC. | COM | $77.9M | 12.0%Prev: 15.0% | 12,916,663 SH | Increased |
| 13F-HR |
| 0001012975-26-000794 |
| $1.10B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001012975-25-000444 | $299.1M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001012975-26-000461 | $677.1M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001012975-25-000245 | $206.2M | View |